vs
Side-by-side financial comparison of BT Brands, Inc. (BTBD) and Opus Genetics, Inc. (IRD). Click either name above to swap in a different company.
Opus Genetics, Inc. is the larger business by last-quarter revenue ($3.9M vs $3.9M, roughly 1.0× BT Brands, Inc.). On growth, Opus Genetics, Inc. posted the faster year-over-year revenue change (-10.2% vs -11.4%). Over the past eight quarters, Opus Genetics, Inc.'s revenue compounded faster (50.3% CAGR vs -1.8%).
BT Brands, Inc.BTBDEarnings & Financial Report
BT Group plc is a British multinational telecommunications holding company headquartered in London, England. It has operations in around 180 countries and is the largest provider of fixed-line, broadband and mobile services in the UK, and also provides subscription television and IT services.
Opus Genetics, Inc. is a clinical-stage biotechnology company specializing in the development of targeted gene therapies for inherited retinal diseases. It focuses on addressing unmet medical needs for patients living with rare, vision-threatening ocular conditions, with operations centered on advancing accessible therapeutic candidates for global rare disease patient populations.
BTBD vs IRD — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $3.9M | $3.9M |
| Net Profit | $915.0K | — |
| Gross Margin | — | — |
| Operating Margin | 19.1% | — |
| Net Margin | 23.7% | — |
| Revenue YoY | -11.4% | -10.2% |
| Net Profit YoY | 516.9% | 53.0% |
| EPS (diluted) | $0.15 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $3.9M | ||
| Q3 25 | $3.9M | $3.1M | ||
| Q2 25 | $3.8M | $2.9M | ||
| Q1 25 | $3.2M | $4.4M | ||
| Q4 24 | — | $4.3M | ||
| Q3 24 | $4.3M | $3.9M | ||
| Q2 24 | $4.1M | $1.1M | ||
| Q1 24 | $3.2M | $1.7M |
| Q4 25 | — | — | ||
| Q3 25 | $915.0K | $-17.5M | ||
| Q2 25 | $55.0K | $-7.4M | ||
| Q1 25 | $-329.8K | $-8.2M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-219.5K | $-7.5M | ||
| Q2 24 | $-70.0K | $-7.8M | ||
| Q1 24 | $-445.7K | $-7.1M |
| Q4 25 | — | — | ||
| Q3 25 | 19.1% | -269.9% | ||
| Q2 25 | -2.0% | -309.0% | ||
| Q1 25 | -9.0% | -227.2% | ||
| Q4 24 | — | — | ||
| Q3 24 | -1.7% | -207.1% | ||
| Q2 24 | -4.6% | -748.9% | ||
| Q1 24 | -19.8% | -450.5% |
| Q4 25 | — | — | ||
| Q3 25 | 23.7% | -566.9% | ||
| Q2 25 | 1.5% | -257.5% | ||
| Q1 25 | -10.2% | -187.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | -5.0% | -194.6% | ||
| Q2 24 | -1.7% | -698.3% | ||
| Q1 24 | -14.0% | -415.3% |
| Q4 25 | — | — | ||
| Q3 25 | $0.15 | $-0.25 | ||
| Q2 25 | — | $-0.12 | ||
| Q1 25 | — | $-0.24 | ||
| Q4 24 | — | — | ||
| Q3 24 | $-0.04 | $-0.29 | ||
| Q2 24 | — | $-0.30 | ||
| Q1 24 | — | $-0.29 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.5M | $45.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $7.7M | $15.3M |
| Total Assets | $11.9M | $50.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $45.1M | ||
| Q3 25 | $3.5M | $30.8M | ||
| Q2 25 | $3.0M | $32.4M | ||
| Q1 25 | $2.7M | $41.8M | ||
| Q4 24 | — | $30.3M | ||
| Q3 24 | $2.0M | $36.6M | ||
| Q2 24 | $1.5M | $41.4M | ||
| Q1 24 | $1.5M | $47.2M |
| Q4 25 | — | $15.3M | ||
| Q3 25 | $7.7M | $6.0M | ||
| Q2 25 | $6.8M | $17.5M | ||
| Q1 25 | $6.7M | $5.1M | ||
| Q4 24 | — | $6.7M | ||
| Q3 24 | $8.5M | $34.3M | ||
| Q2 24 | $8.7M | $40.6M | ||
| Q1 24 | $8.8M | $46.1M |
| Q4 25 | — | $50.2M | ||
| Q3 25 | $11.9M | $36.1M | ||
| Q2 25 | $11.2M | $38.7M | ||
| Q1 25 | $11.0M | $48.2M | ||
| Q4 24 | — | $36.9M | ||
| Q3 24 | $13.7M | $40.4M | ||
| Q2 24 | $14.0M | $44.8M | ||
| Q1 24 | $14.0M | $51.8M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $325.2K | $-35.3M |
| Free Cash FlowOCF − Capex | $261.8K | — |
| FCF MarginFCF / Revenue | 6.8% | — |
| Capex IntensityCapex / Revenue | 1.6% | — |
| Cash ConversionOCF / Net Profit | 0.36× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-35.3M | ||
| Q3 25 | $325.2K | $-6.2M | ||
| Q2 25 | $384.4K | $-10.3M | ||
| Q1 25 | $-306.7K | $-9.0M | ||
| Q4 24 | — | $-25.6M | ||
| Q3 24 | $129.3K | $-5.1M | ||
| Q2 24 | $82.5K | $-7.3M | ||
| Q1 24 | $-408.9K | $-5.7M |
| Q4 25 | — | — | ||
| Q3 25 | $261.8K | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $-431.1K | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $50.4K | — | ||
| Q2 24 | $53.7K | — | ||
| Q1 24 | $-521.3K | — |
| Q4 25 | — | — | ||
| Q3 25 | 6.8% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -13.3% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.2% | — | ||
| Q2 24 | 1.3% | — | ||
| Q1 24 | -16.3% | — |
| Q4 25 | — | — | ||
| Q3 25 | 1.6% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 3.8% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.8% | — | ||
| Q2 24 | 0.7% | — | ||
| Q1 24 | 3.5% | — |
| Q4 25 | — | — | ||
| Q3 25 | 0.36× | — | ||
| Q2 25 | 6.98× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
